Live feed
Filing
SC 13G/A
SC 13G/A0000080255-18-002782·Neurogene Inc.
Schedule 13G ownership disclosure
AQUINOX PHARMACEUTICALS, INC
Security class unavailable · CUSIP: 03842B101
Event date: 2018-06-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,350,000
- Percent of class
- 5.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000080255-18-002782
- Form type
- SC 13G/A
- Filer
- Neurogene Inc.
- CIK
- CIK 1404644
- Filed
- Jul 10, 2018
- Reporting period
- Jun 30, 2018
- Description
- Schedule 13G beneficial ownership